Sacral Nerve Stimulation Market Size to Grow by $ 192.50 mn through 2020-2024
The sacral nerve stimulation market is expected to grow by $ 192.50 mn, accelerating at a CAGR of almost 5% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. View Free Sample Report
Sacral Nerve Stimulation Market: Segmentation by Product
This report provides a detailed analysis of the market by Product (Implantable SNS devices and External SNS devices), Geography (North America, Europe, APAC, and ROW), and End-user (Hospitals and ASCs). This research report will provide insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges which are likely to influence market growth during the forecast period. These insights are expected to equip clients with reliable information based upon which they can design a growth strategy for their business and area of operations.
Sacral Nerve Stimulation Market: Vendor Analysis
The market is concentrated. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Axonics Modulation Technologies Inc., Boston Scientific Corp., Laborie Medical Technologies Corp., LivaNova Plc, Medtronic Plc, NeuroPace Inc., Nevro Corp., Nuvectra Corp., and Synapse Biomedical Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
Technavio has been monitoring the Global Sacral Nerve Stimulation Market and it is expected to grow by USD 192.50 million accelerating at a CAGR of over 5% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. Download latest version with COVID-19 analysis Free Sample Report
Sacral Nerve Stimulation Market: Increasing Geriatric Population With Sacral Nerve Issues to Drive Growth
The incidence of sacral nerve issues are increasing due to the rise in the aging population, as the chances of developing degeneration of anal sphincters increase with age. People often ignore the issues related to muscle degeneration in the geriatric population, resulting in increase in the number of patients with such conditions. The sacral nerve is responsible for controlling the muscles associated with bladder and bowel movement.
North America will offer several growth opportunities to market vendors during the forecast period. 35% of the market growth will originate from North America during the forecast period. Apart from the market leader North America, the emerging countries such as India and China have a large pool of under-served patients, which presents significant opportunities for vendors to expand their market for SNS devices, which will result in the growth of this industry during the forecast period.
Sacral Nerve Stimulation Market: Vendor Analysis
The market is concentrated due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Axonics Modulation Technologies Inc., Boston Scientific Corp., Laborie Medical Technologies Corp., LivaNova Plc, Medtronic Plc, NeuroPace Inc., Nevro Corp., Nuvectra Corp., and Synapse Biomedical Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio offers custom research reports with detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19 Download a Free Sample Report
